These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 12180312

  • 21. Hepatitis C virus in the transplant setting.
    Berenguer M, Wright TL.
    Antivir Ther; 1998; 3(Suppl 3):125-36. PubMed ID: 10726062
    [Abstract] [Full Text] [Related]

  • 22. [Hepatitis C].
    Moradpour D, Blum HE.
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [Abstract] [Full Text] [Related]

  • 23. [Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
    Imazeki F.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):540-3. PubMed ID: 15359858
    [No Abstract] [Full Text] [Related]

  • 24. [Treatment of chronic hepatitis C in children].
    Bernard O.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B206-9. PubMed ID: 12180290
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract] [Full Text] [Related]

  • 26. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N, Rizzetto M.
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of hepatitis C: advances and consensus].
    Lerebours E, Marcellin P, Dhumeaux D.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B5-6. PubMed ID: 12180308
    [No Abstract] [Full Text] [Related]

  • 28. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract] [Full Text] [Related]

  • 29. [Treatment of chronic hepatitis C].
    Rókusz L.
    Orv Hetil; 2004 Aug 08; 145(32):1649-53. PubMed ID: 15384863
    [Abstract] [Full Text] [Related]

  • 30. [International consensus conference on hepatitis C. Conclusions. Organized under the auspices of the European Association for the Study of the Liver (EASL)].
    Ann Med Interne (Paris); 1999 Sep 08; 150(5):449-53. PubMed ID: 10544760
    [No Abstract] [Full Text] [Related]

  • 31. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF.
    Antivir Ther; 2006 Sep 08; 11(8):985-94. PubMed ID: 17302368
    [Abstract] [Full Text] [Related]

  • 32. [Evaluating the efficacy of interferon therapy on hepatitis C patients].
    Shiraha H, Iwasaki Y, Shiratori Y.
    Nihon Rinsho; 2004 Jul 08; 62 Suppl 7(Pt 1):489-92. PubMed ID: 15359847
    [No Abstract] [Full Text] [Related]

  • 33. The faster the better?
    Carulli N.
    Intern Emerg Med; 2006 Jul 08; 1(2):91-3. PubMed ID: 17111779
    [No Abstract] [Full Text] [Related]

  • 34. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
    Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, Watanabe H.
    J Gastroenterol Hepatol; 2006 Jan 08; 21(1 Pt 1):122-8. PubMed ID: 16706823
    [Abstract] [Full Text] [Related]

  • 35. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S, Kubo S, Shiomi S.
    Nihon Rinsho; 2004 Jul 08; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Quality of life of patients with chronic hepatitis C: effect of treatments].
    Couzigou P.
    Gastroenterol Clin Biol; 2002 Apr 08; 26 Spec No 2():B257-63. PubMed ID: 12180299
    [No Abstract] [Full Text] [Related]

  • 38. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
    Iyoda K, Kato M.
    Nihon Rinsho; 2004 Jul 08; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
    [No Abstract] [Full Text] [Related]

  • 39. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M, Minola E, Guido M, Boccagni P, De Feo TM, Torelli R, Cardillo M, Scalamogna M, Poli F.
    Liver Transpl; 2009 Apr 08; 15(4):390-9. PubMed ID: 19326408
    [Abstract] [Full Text] [Related]

  • 40. Review article: the treatment of hepatitis C virus recurrence after liver transplantation.
    Arjal RR, Burton JR, Villamil F, Rosen HR.
    Aliment Pharmacol Ther; 2007 Jul 15; 26(2):127-40. PubMed ID: 17593060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.